Aduro Biotech - 48 Year Dividend History | ADRO

Historical dividend payout and yield for Aduro Biotech (ADRO) since 1971. The current TTM dividend payout for Aduro Biotech (ADRO) as of June 17, 2019 is $0.00. The current dividend yield for Aduro Biotech as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.143B $0.015B
Aduro Biotech, Inc. is an immunotherapy company. The Company develops technology and vaccines for the treatment of cancer and mesothelin-expressing tumors. Its product pipeline includes CRS-207, ADU-623, ADU-214, ADU-741, CDN and STINGVAX which are in different clinical trial. Aduro Biotech, Inc. is based in BERKELEY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83